0.3g;0.6g;1.2g

√  Protect liver for patients with hepatitis;

√  Protect against toxicity during cancer chemotherapy

√  Market in over 2000 hospitals in China and sell over 30 million vials per year;

√  High Quality products of YAOPHARMA:

    - API imported from Japan;

    - State-of-the-art manufacturing equipment;

    - 10+ years of experience in producing GSH (sterilized lyophilized injection).

*Injectables (available for Asia, Africa and South America)

5 mcg; 10 mcg

√ Innovative and Unique Dosage Form

- Dried emulsion for injection (Freeze-dried).

- An innovative formulation advantageous over regular Alprostadil.

√ Targeting Indications

- Improve cardiovascular and cerebrovascular microcirculation

- Peripheral vascular disease-treating ulcer induced by chronic arterial occlusive disease...

Nano-composite Emulsion Technology

- Alprostadil is encapsulated in lipid microsphere-Prolonged half-life

- Targeted delivery system--targeting vascular lesion

- Less Alprostadil is used- safer and less adverse effects

*Injectables (available for Asia, Africa and South America)

0.1g; 0.2g

√ Anti-oxidation agent; Protects liver in hepatic diseases treatment;

√ Film-coated tablets, easy administration;

√ Perfect choice for maintenance treatment after treatment of Reduced Glutathione for Injection;

√ The only manufacturer in China, no direct competition;

√ High Quality products of YAOPHARMA:

- API imported from Japan;

- US FDA approved GMP system;

*Oral Solids (available for Asia, Africa and South America)

0.25 mcg; 0.5 mcg

√ Bypasses kidney metabolism, alleviating burden on kidney.

√ Inhibits bone absorption, facilitates bone formation, and improves bone quality.

√ Dual function of bone calcium mobilization and bone calcium deposition.

√ High Quality products of YAOPHARMA:

- Unique solid-dispersing technology: ensuring uniformity and stability of API in ultra-low concentration.

- US FDA approved GMP system;

*Oral Solids (available for Asia, Africa and South America)

Strength:

25mg;37.5mg; 50mg;75mg;100mg

Indication:

Major depressive disorder

* ANDA Pipeline (available for EU and North America)

Strength:

20 mg;30 mg;60 mg

Indication:

√ Major Depressive Disorder (MDD)

√ Generalized Anxiety Disorder (GAD)

√ Diabetic Peripheral Neuropathic Pain (DPNP)

√ Chronic Musculoskeletal Pain

* ANDA Pipeline (available for EU and North America)

Strength:

25mg;50mg;100mg;200mg

Indication:

√ Hypertension,

√ Angina Pectoris

√ Heart Failure

* ANDA Pipeline (available for EU and North America)